Skip to main content

Hammerhead Ribozyme-Mediated Knockdown of mRNA for Fibrotic Growth Factors: Transforming Growth Factor-Beta 1 and Connective Tissue Growth Factor

  • Protocol
  • First Online:
Cytokine Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 820))

Abstract

Excessive scarring (fibrosis) is a major cause of pathologies in multiple tissues, including lung, liver, kidney, heart, cornea, and skin. The transforming growth factor-β (TGF-β) system has been shown to play a key role in regulating the formation of scar tissue throughout the body. Furthermore, connective tissue growth factor (CTGF) has been shown to mediate most of the fibrotic actions of TGF-β, including stimulation of synthesis of extracellular matrix and differentiation of fibroblasts into myofibroblasts. Currently, no approved drugs selectively and specifically regulate scar formation. Thus, there is a need for a drug that selectively targets the TGF-β cascade at the molecular level and has minimal off-target side effects. This chapter focuses on the design of hammerhead ribozymes, measurement of kinetic activity, and assessment of knockdown mRNAs of TGF-β and CTGF in cell cultures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Border, W.A., Noble, N.A., Yamamoto, T., Harper, J.R., Yamaguchi, Y., Pierschbacher, M.D. Ruoslahti, E. (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361–364.

    Article  PubMed  CAS  Google Scholar 

  2. Border, W. A., Noble, N. A. (1994) Trans­forming Growth Factor B in Tissue Fibrosis. N. Engl. J. Med. 331: 1286–1292.

    Article  PubMed  CAS  Google Scholar 

  3. Grotendorst, G.R., Duncan, M.R. (2005) Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 19: 729–738.

    Article  PubMed  CAS  Google Scholar 

  4. Lewin, A., Hauswirth, W. (2007) Ribozyme gene therapy: applications for molecular medicine. Trends Mol. Med. 7: 221–228.

    Article  Google Scholar 

  5. Lee, P.A., Blatt, L.M., Blanchard, K.S., Bouhana, K.S., Pavco, P.A., Bellon, L., Sandberg, J.A. (2000) Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice. Hepatology 32: 640646.

    Article  PubMed  CAS  Google Scholar 

  6. Shimayama, T., Nishikawa, S., Taira, K. (1995) Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes. Biochemistry 34: 3649–3654.

    Article  PubMed  CAS  Google Scholar 

  7. Fritz, J.J., Lewin, A., Hauswirth, W., Agarwal, A., Grant, M., Shaw, L. (2002) Development of hammerhead ribozymes to modulate endogenous gene expression for functional studies. Methods 28: 276–285.

    Article  PubMed  CAS  Google Scholar 

  8. Drenser, K.A., Timmers, A.M., Hauswirth, W.W., Lewin, A.S. (1998) Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 39: 681–689.

    PubMed  CAS  Google Scholar 

  9. Heid, C.A., Stevens, J., Livak, K.J., Williams, D.M. (1996) Real time quantitative PCR. Genome Res. 10: 984–986.

    Google Scholar 

  10. Blalock, T.D., Duncan, M.R., Varela, J.C., Goldstein, M.H., Tuli, S.S., Grotendorst, G.R., Schultz, G.S. (2003) Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 44: 1879–1887.

    Article  PubMed  Google Scholar 

  11. Tamatani, T., Kobayashi, H., Tezuka, K., Sakamoto, S., Suzuki, K., Nakanishi, T., Takigawa, M., Miyano, T. (1998) Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem. Biophys. Res. Commun. 251: 748–752.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregory S. Schultz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Robinson, P.M., Blalock, T.D., Yuan, R., Lewin, A.S., Schultz, G.S. (2012). Hammerhead Ribozyme-Mediated Knockdown of mRNA for Fibrotic Growth Factors: Transforming Growth Factor-Beta 1 and Connective Tissue Growth Factor. In: De Ley, M. (eds) Cytokine Protocols. Methods in Molecular Biology, vol 820. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-439-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-439-1_8

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-438-4

  • Online ISBN: 978-1-61779-439-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics